Pharmacology NUR3196 Exam 1 with
complete solutions
Schedule 1 drugs are - ANSWER-Defined as drugs, substances, or
chemicals with no currently accepted medical use and a high potential
for abuse.
Heroin, lysergic acid diethylamide (LSD), marijuana* (cannabis), 3,4-
methylenedioxymethamphetamine (MDMA, ecstasy), methaqualone,
and peyote
Schedule ll drugs are - ANSWER-Defined as drugs, substances, or
chemicals with a high potential for abuse, with use potentially leading
to severe psychological or physical dependence. These drugs are also
considered dangerous.
Combination products with less than 15 mg of hydrocodone per
dosage unit, cocaine, methamphetamine, methadone, hydromorphone,
meperidine, oxycodone, fentanyl, dextroamphetamine,
dextroamphetamine/amphetamine, and methylphenidate
Schedule lll drugs are - ANSWER-Defined as drugs, substances, or
chemicals with a moderate to low potential for physical and
psychological dependence. Schedule III drug abuse potential is less
than schedule I and schedule II drugs but more than schedule IV.
Products containing less than 90 mg of codeine per dosage unit
(acetaminophen with codeine), ketamine, anabolic steroids, and
testosterone
Schedule IV - ANSWER-Defined as drugs, substances, or chemicals
with a low potential for abuse and low risk for dependence.
Alprazolam, carisoprodol, diazepam, lorazepam, zolpidem, and
tramadol
, Pharmacology NUR3196 Exam 1 with
complete solutions
Schedule V - ANSWER-Defined as drugs, substances, or chemicals
with lower potential for abuse than schedule IV and consist of
preparations containing limited quantities of certain narcotics.
Schedule V drugs are generally used for antidiarrheal, antitussive, and
analgesic purposes.
Cough preparations with less than 200 mg of codeine or per 100 mL,
codeine/guaifenesin, diphenoxylate/atropine, difenoxin/atropine, and
pregabalin
Epinephrine dose/admin for adults - ANSWER-SQ/IM: 0.2 to 0.5 mg
(0.2 to 0.5 mL of 1:1000 solution)
May repeat q5-15 min if anaphylaxis persists or q15-20 min for
hypersensitivity
(Epinephrine [EpiPen] autoinjector provides a 0.3-mg dose)
IV: 0.1 to 0.25 mg of 1:10,000 solution infused slowly over 5 to 10
minMay repeat q5-15 min as neededMay follow with 1 to 4 mcg/min
infusion
for cardiac arrest,
IV: Initially, 1 mg; may repeat q3-5 min as neededEndotracheal: 2 to
2.5 mg q3-5 min as needed
Epinephrine dosage/admin for children - ANSWER-SQ/IM: 0.01
mg/kg (0.001 mg/kg of 1:1000 solution).
May repeat q5-15 min
Maximum dose: 0.3 mg
(Epinephrine [EpiPen] autoinjector provides a 0.15-mg dose)
, Pharmacology NUR3196 Exam 1 with
complete solutions
Asthma: Bronchodilators for adults - ANSWER-SQ: 0.3 to 0.5 mg
(0.3 to 0.5 mL of 1:1000 solution) q20 min times three doses, if
needed
Nebulizer: Add 0.5 mL to hand bulb nebulizer: one to three
inhalations up to q3h, if needed
Side effects and adverse effects of epinephrine - ANSWER-CNS:
Tremors, anxiety, dizziness, insomnia
RESP: Dyspnea
CV: Palpitations, tachycardia
GI: Anorexia, nausea, vomiting
Adverse effects
CV: Palpitations, tachycardia, hypertension, tissue necrosis at IV site
upon infiltrationLife-threatening: Ventricular fibrillation, pulmonary
edema
Albuterol for adults and children older than 12 years - ANSWER-PO:
2 to 4 mg, t.i.d./q.i.d.; max: 32 mg/d in four divided doses
SR: 4 to 8 mg, q12h
Inhaler: 1 to 2 puffs q4-6h PRN
Nebulizer: 0.5 mL of 0.5% solution in 3 mL of 0.9% NaCl in 5 to 15
min
Side effects and adverse effects of albuterol - ANSWER-CNS:
Tremors, anxiety, restlessness
CV: Palpitations, tachycardia, angina
EENT: Dry nose, irritation of nose and throat